Schott Pharma

Last updated
Schott Pharma AG & Co. KGaA
Company type KGaA with Aktiengesellschaft as partner with unlimited liability
FWB:  1SXP
ISIN DE000A3ENQ51
Industry Healthcare
FoundedAugust 1, 2022;2 years ago (2022-08-01)
Headquarters Mainz, Germany
Key people
Andreas Reisse, CEO
Almuth Steinkühler, CFO
ProductsPharmaceutical drug containment and delivery systems
Revenue€899 million (2022/2023) [1]
Owner Schott AG
Number of employees
4,646 (as of September 30, 2023) [1]
Divisions
  • Drug Containment Solutions
  • Drug Delivery Systems
Website schott-pharma.com

Schott Pharma (stylized as SCHOTT Pharma) is a provider of drug containment solutions and delivery systems for injectable drugs. [2] [3] Originally a division of glass manufacturer Schott AG, the company went public on the Frankfurt Stock Exchange in 2023. [4] Headquartered in Mainz, Germany, [5] [6] the company operates in 14 countries. [7]

Contents

History

Filling Schott glass ampoules with medications (1932) Abfullautomat 1932 SCHOTT.jpg
Filling Schott glass ampoules with medications (1932)
Schott & Gen. advertisement for borosilicate glass vials (1923) Druckschrift Fiolenkorper 1923 SCHOTT.jpg
Schott & Gen. advertisement for borosilicate glass vials (1923)

In 1887, Otto Schott developed borosilicate glass, a form of glassware used to reagent bottles and flasks. From 1911, Schott manufactured borosilicate glass tubing for the production of pharmaceutical ampoules and vials. [8]

Schott Pharma was established as a standalone company in 2022 under the name Schott Pharma AG & Co. KGaA [9] [6] through an equity carve-out (or spin-off) from Schott AG, a manufacturer of specialty glass and glass-ceramics. [10] [11] In the same year, the company announced their plans to present an IPO, but this was reportedly postponed to 2023 due to the Russian invasion of Ukraine. [5]

In June 2023, Schott Pharma announced plans to hold the IPO in September 2023. [12] This plan was enacted in September, with Schott Pharma going public on the Frankfurt Stock Exchange. [13] The IPO was initially priced at 27€ per share, [14] [15] and a potential valuation of up to 4.1 billion euros, [16] but increased the share price to 30€ the following day. [17] [13] The IPO was the largest of the year in Germany. [18] [19] In December 2023, Schott Pharma was included in the SDAX. [20] In September 2024, Schott Pharma was promoted to the MDAX. [21]

Production & Manufacturing

The company is headquartered in Mainz and operates in 16 locations across 14 countries. [22]

Europe

North America

South America

Asia

Products

Schott Pharma develops and manufactures drug containment solutions and delivery systems for injectable drugs, which it supplies to companies in the biotechnology and pharmaceutical industries. [31]

Its business is divided into two divisions:

Governance

Schott Pharma is a subsidiary of SCHOTT AG, which holds controlling shares (as of 2023: 77%). [19] [17] SCHOTT AG is owned by the Carl Zeiss Foundation. [25]

Schott Pharma is listed on the Frankfurt Stock Exchange's MDAX. [21]

Independent Supervisory Board

In 2023 SCHOTT AG appointed a Supervisory Board for the subsidiary Schott Parma AG as follows: [34] [35]

Financial Results

2022/232023/24
Turnover
Net Profit

Related Research Articles

<span class="mw-page-title-main">DAX</span> Blue chip stock market index

The DAX is a stock market index consisting of the 40 major German blue chip companies trading on the Frankfurt Stock Exchange. It is a total return index. Prices are taken from the Xetra trading venue. According to Deutsche Börse, the operator of Xetra, DAX measures the performance of the Prime Standard's 40 largest German companies in terms of order book volume and market capitalization. DAX is the equivalent of the UK FTSE 100 and the US Dow Jones Industrial Average, and because of its small company selection it does not necessarily represent the vitality of the German economy as a whole.

<span class="mw-page-title-main">Frankfurt Stock Exchange</span> 12th largest stock exchange by market capitalization

The Frankfurt Stock Exchange is the world's 3rd oldest and 12th largest stock exchange by market capitalization. It has operations from 8:00 am to 10:00 pm.

<span class="mw-page-title-main">Schott AG</span> German glass company

Schott AG is a German multinational glass company specializing in the manufacture of glass and glass-ceramics. Headquartered in Mainz, Rhineland-Palatinate, Germany, it is owned by the Carl Zeiss Foundation. The company's founder and namesake, Otto Schott, is credited with the invention of borosilicate glass.

The MDAX is a stock index which lists German companies trading on the Frankfurt Stock Exchange. The index is calculated by Deutsche Börse.

The Prime Standard is a market segment of the Frankfurt Stock Exchange that includes companies which comply with transparency standards higher than those of the General Standard, which is regulated by law. The Prime Standard includes quarterly reporting as well as ad hoc disclosure in German and English, application of international accounting standards, publication of a financial calendar and staging of at least one analyst conference per year. Companies must satisfy the requirements of the Prime Standard to be listed in the DAX, MDAX, TecDAX and SDAX.

<span class="mw-page-title-main">Siltronic</span> Silicon wafer manufacturer

Siltronic AG is a manufacturer of wafers made of hyperpure silicon, the basis for modern micro- and nanotechnology. The Munich-based company is one of the world's leading manufacturers of wafers for the semiconductor industry.

<span class="mw-page-title-main">Bechtle</span> Company

Bechtle AG is a multinational technology company with a business model combining information technology services with the direct sale of hardware and software IT products, as well as the operation and maintenance of IT infrastructure for industrial customers and public-sector clients. The Bechtle Group is headquartered in Neckarsulm, Baden-Württemberg, and organised into multiple parent and holding companies.

Tele Columbus is a large internet service provider in Germany with 3.6 million connected households via its Tier 3 network. Tele Columbus' services have been offered under the newly created umbrella brand PŸUR since September 2017.

<span class="mw-page-title-main">Fielmann AG</span> German eyewear company

Fielmann Group AG is a German eyewear company.

<span class="mw-page-title-main">Deutsche EuroShop</span> German Real Estate Investment Company

Deutsche EuroShop AG is an internationally active German real estate investment company headquartered in Hamburg. It is the largest German investor in shopping centers, and the country's only publicly traded company to do so exclusively. At the end of 2023, the firm held investments in 21 properties in Germany, Austria, Poland, Czech Republic and Hungary.

BB Biotech AG is a Swiss investment company in the field of biotechnology. The company invests mainly in the United States and Western Europe and is managed by Bellevue Asset Management, a division of Bellevue Group, which is listed on the Swiss Stock Exchange.

Rational AG is a German manufacturer and retailer of commercial and industrial kitchen equipment for thermal food preparation. The company is based in Landsberg am Lech, Germany, and was founded by Siegfried Meister in 1973. It operates worldwide and has 25 subsidiaries in Europe, Asia, North and South America as well as seven branches in Germany.

bet-at-home.com European online gambling and sports betting company

bet-at-home.com AG is a European online gambling and sports betting company that was founded in 1999.

<span class="mw-page-title-main">Nipro</span> Japanese medical equipment manufacturer

Nipro Corporation is a Japanese medical equipment manufacturing company. Founded in 1954, the company is headquartered in Osaka and is listed on the Tokyo Stock Exchange and the Osaka Securities Exchange. As of 2013 the company has 58 subsidiaries in Japan, Asia, North and South America and Europe. February 2018, the Company enters the endoscope-related business by making Machida Corporation its subsidiary.

<span class="mw-page-title-main">Talanx</span> German multinational financial services company

Talanx is a German multinational financial services company headquartered in Hanover, Germany. Its core businesses include reinsurance, insurance and asset management. Talanx is Germany's third-largest insurance group and one of the major European insurance groups by premium income. The group operates in more than 150 countries.

<span class="mw-page-title-main">Grenke</span>

Grenke AG is a German manufacturer-independent leasing company which is specialized in office communication-products, including printers, copiers, telephone systems, servers and laptop computers. Besides its leasing-activities, Grenke makes a notable portion of its revenue with factoring services. By acquiring the German private bank Hesse Newman in 2009, the company obtained a banking license. The most important markets for the company are Germany, France and Italy.

<span class="mw-page-title-main">TeamViewer (company)</span> German technology company

TeamViewer SE is an international technology company headquartered in Göppingen, Germany. The company became known for the TeamViewer remote access and support software of the same name. Within the TeamViewer software, customers can connect, monitor, and control computers, machines, and other devices. It can be used in various industries, for example, to digitalize processes along the industrial value chain. The company is listed on the stock exchange and is a member of MDAX and TecDAX.

Scout24 SE is a German publicly-listed digital company headquartered in Munich, operating the online marketplace ImmoScout24. The ImmoScout24 multi-platform attracted over 20 million visitors monthly in Germany in 2021, either through the website or the app.

ATOSS Software SE is a publicly listed company that provides software for workforce management.

Cancom SE is a German company for IT services based in Munich in the field of cloud computing. Cancom was the sixth-largest IT systems house in Germany in 2023.

References

  1. 1 2 SCHOTT Pharma Annual Report 2022/2023 (accessed February 08, 2024)
  2. ↑ Kansteiner, Fraiser (2023-12-23). "Glass specialist Schott Pharma touts 2023 sales growth, Serbia expansion and hiring plans". Fierce Pharma. Retrieved 2024-04-08.
  3. ↑ "EQS-News: SCHOTT Pharma bestätigt Prognose für das Geschäftsjahr 2024 anlässlich seiner Q2-Ergebnisse; Geschäftsjahr 2025 durch geringeres Wachstum bei Spritzen beeinflusst" [EQS-News: SCHOTT Pharma confirms forecast for the 2024 financial year on the occasion of its Q2 results; financial year 2025 influenced by lower growth in syringes]. 4Investors.de (in German). 2024-05-14. Retrieved 2024-06-24.
  4. ↑ Rauffmann, Theresa (2024-06-27). "Abhängigkeit vom Geschäft mit Diätspritzen wird zum Problem" [Dependence on the business with diet syringes becomes a problem]. www.handelsblatt.com. Retrieved 2024-09-18.
  5. 1 2 Ibrahim, Samir (2023-09-28). "Schott Pharma startet erfolgreich an der Frankfurter Börse". tagesschau.de (in German). Retrieved 2024-06-24.
  6. 1 2 3 Nünchert, Ike (2022-08-03). "SCHOTT Pharma: Carve-Out für ein mögliches IPO" [SCHOTT Pharma: Carve-Out for a possible IPO]. Going Public. Retrieved 2024-06-24.
  7. ↑ "Größter Börsengang in 2023: So hat sich die SCHOTT Pharma-Aktie seit ihrem IPO entwickelt - und so könnte es in 2024 nun weitergehen". finanzen.net. 2024-01-24. Retrieved 2024-02-28.
  8. ↑ "Impfstoff-Ampullen – Rohrglas für Lebensretter - VBG Spezial". glaskeramik.org. VBG. 2021-07-04. Retrieved 2024-02-28.
  9. ↑ Dunleavy, Kevin (2023-09-06). "After one year as standalone business, glassmaker Schott Pharma sets course for IPO". Fierce Pharma. Retrieved 2024-06-24.
  10. ↑ Kansteiner, Fraiser (2022-01-08). "Glass maker Schott's pharma business sets out on its own. Will an IPO follow?". Fierce Pharma. Retrieved 2024-02-28.
  11. ↑ Landsteiner, Fraiser (2022-08-01). "Glass maker Schott's pharma business sets out on its own. Will an IPO follow?". Fierce Pharma. Retrieved 2024-06-24.
  12. ↑ Wilkes, William; Gopinath, Swetha (2023-06-22). "Schott to Hold IPO of Medical Glassware Unit in September: Bloomberg.com". Bloomberg.com: N.PAG–N.PAG.
  13. 1 2 "Schott Pharma trades up following biggest German IPO since Porsche: Global Capital". Global Capital: N.PAG–N.PAG. 2023-10-16.
  14. ↑ Gopinath, Swetha (2023-09-28). "Germany's Schott Raises €813 Million in IPO of Medical-Glass Arm". www.bloomberg.com. Retrieved 2024-06-24.
  15. ↑ gsp (2023-09-29). "Schott Pharma geht mit Freshfields an die Frankfurter Börse" [Schott Pharma goes to the Frankfurt Stock Exchange with Freshfields]. Extrajournal.Net (in German). Retrieved 2024-06-24.
  16. ↑ "Schott Pharma prices IPO at 27 euros per share". Reuters. 2023-09-27. Retrieved 2024-06-24.
  17. 1 2 "SCHOTT Pharma feiert erfolgreiches Börsendebüt: Erstkurs über Ausgabepreis" [SCHOTT Pharma celebrates successful stock market debut: First price on issue price]. Finanzen Net (in German). 2023-09-28. Retrieved 2024-06-24.
  18. ↑ Farr, Emma-Victoria; Mayo Cerqueiro, Pablo (2023-09-28). "Schott Pharma shares jump 16% in Frankfurt trading debut". reuters.com. Reuters. Retrieved 2024-02-28.
  19. 1 2 "Schott Pharma startet erfolgreich an der Börse". tagesschau.de. 2023-09-28. Retrieved 2024-02-28.
  20. ↑ Ingerl, Christian (2023-12-13). "Profitabler Small Cap: Zulieferer Schott Pharma bald im SDax". Capital. Retrieved 2024-02-28.
  21. 1 2 Ruhkamp, Christoph (2024-10-04). "Finanzchefin bringt Schott Pharma in den MDax" [Chief Financial Officer brings Schott Pharma into the MDax]. boersen-zeitung.de (in German). Retrieved 2024-11-04.
  22. ↑ "Größter Börsengang in 2023: So hat sich die SCHOTT Pharma-Aktie seit ihrem IPO entwickelt - und so könnte es in 2024 nun weitergehen". finanzen.net. 2024-01-24. Retrieved 2024-02-28.
  23. ↑ Zeitung, Badische (2022-12-02). "SCHOTT Pharma: Ein globales Kompetenzzentrum in Müllheim". Badische Zeitung (in German). Retrieved 2024-06-24.
  24. ↑ Schlegel, Marion (2023-12-19). "SDAX-Neuling Schott Pharma gibt ordentlich Gas: Zahlen kommen gut an". www.deraktionaer.de (in German). Retrieved 2024-06-24.
  25. 1 2 3 "SCHOTT Pharma baut Produktion in China und Ungarn aus – ZWP online – das Nachrichtenportal für die Dentalbranche". www.zwp-online.info (in German). 2022-09-22. Retrieved 2024-06-24.
  26. 1 2 "SCHOTT: solides Ergebnis trotz konjunktureller Herausforderungen – ZWP online – das Nachrichtenportal für die Dentalbranche" [SCHOTT: solid result despite economic challenges]. www.zwp-online.info (in German). 2024-02-12. Retrieved 2024-06-24.
  27. 1 2 Herpai, Gergely (2024-07-12). "Schott Pharma's HUF 28 bln Investment Boosts Hungarian Pharmaceutical Manufacturing: Budapest Business Journal". Budapest Business Journal. 32 (14): 8–8.
  28. ↑ "Schott Pharma Begins Construction on Serbia Plant: American Ceramic Society Bulletin". American Ceramic Society Bulletin. 103 (5): 49–49. July 2024.
  29. 1 2 Schott (2024-03-18). "SCHOTT Pharma to Expand in the U.S. with New Prefillable Syringe Manufacturing Facility in Wilson, North Carolina: Business Wire (English)". Business Wire (English).
  30. ↑ Anselmo, Joelle (2024-03-27). "Schott Pharma to build $371M syringe factory: Construction Dive". Construction Dive: N.PAG–N.PAG.
  31. ↑ SCHOTT Pharma Annual Report 2022/2023, SCHOTT Pharma, p. 14, retrieved 2024-02-28
  32. ↑ Kaiser, Lea (2023-10-24). "Next generation pharma glass: SCHOTT AG launches FIOLAX® Pro Glass tubing". BusinessWire. Retrieved 2024-06-24.
  33. ↑ "Schott Pharma rolls out pre-filled polymer syringes for deep-cold medication". NS Medical Devices. 2023-05-18. Retrieved 2024-02-28.
  34. ↑ Mills, Jess (2023-05-02). "Schott appoints Supervisory Board of Schott Pharma". Glass International. Retrieved 2024-06-24.
  35. ↑ "SCHOTT bestellt Aufsichtsrat der SCHOTT Pharma AG" [SCHOTT appoints Supervisory Board of SCHOTT Pharma AG]. ZWP-online. 2023-05-02. Retrieved 2024-06-24.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.